Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 47 are a HOLD (38.84%), 73 are a BUY (60.33%), 1 are a SELL (0.83%).
Analyst Luca Issi works at RBC with a stock forecast success ratio of 34.53% fulfilled within 93.26 days on average.
Luca Issi’s has documented 239 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRNA, Moderna at 03-May-2024.
Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 1/29/2024. The price target of $25 was fulfilled within 7 days with a profit of $6.98 (38.73%) receiving and performance score of 55.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$4.93 (160.59%)
9
2 months 9 days ago
0/3 (0%)
$2.86 (55.64%)
Buy
10
$6.93 (225.73%)
12
3 months 17 days ago
1/7 (14.29%)
$6.91 (223.62%)
28
Buy
10
$6.93 (225.73%)
12
3 months 17 days ago
0/5 (0%)
$6.91 (223.62%)
Buy
18
3 months 28 days ago
2/9 (22.22%)
$12.2 (210.34%)
94
Hold
35
4 months 1 days ago
1/2 (50%)
$19.71 (128.91%)
6
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?